Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peripheral Nerve Injections for Upper Extremity CRPS
NCT04744675Phase 2Active, not recruiting
- Sponsor
- Ottawa Hospital Research Institute
- Start
- May 2024
- Primary completion
- Jul 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine hydrochloride 0.75% injection, triamcinolone in complex regional pain syndrome (CRPS), sponsored by Ottawa Hospital Research Institute. Started May 2024; status: active, not recruiting.
02
Drugs
bupivacaine hydrochloride 0.75% injectiontriamcinolone
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on NCT04744675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04744675.